News

Cambridge, UK and Indianapolis, US – 2 July 2018: Acacia Pharma Group plc (“Acacia Pharma”, the “Company” or the “Group”), (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules

May 23, 2018 at 4:05 PM EDT — Non-dilutive financing extends cash reach to over two years — RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–May 23, 2018– TransEnterix, Inc. (NYSE American: TRXC) (the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. announced today that it has entered into a $100 million venture debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. “Hercules is pleased to enter into this financing partnership with Tricida at this important stage